450
Participants
Start Date
June 1, 2024
Primary Completion Date
January 1, 2025
Study Completion Date
March 1, 2025
Oral intake of medication
● Group A: Received Citalopram hydrobromide, starting with 10 mg once daily for 1 week, followed by 20 mg once daily for 10 weeks, and 10 mg daily during the final week (tapered).
Oral intake of medication
● Group B: Received Silodosin 4mg, administered orally once daily.
Oral intake of medication
● Group C: Received Dapoxetine hydrochloride 30 mg, taken 2 hours before intercourse, on-demand, minimum of 8 times/month for 3 months.
Oral intake of medication
● Group D: Received Dapoxetine hydrochloride 30 mg, administered daily.
Beni-Suef university, Banī Suwayf
Beni-Suef University
OTHER